Glycopeptides related to β-endorphin adopt helical amphipathic conformations in the presence of lipid bilayers

Journal of the American Chemical Society

Volumn 127, Issue 15, 2005, Pages 5435-5448

  Dhanasekaran, Muthu ^a   Palian, Michael M ^a   Alves, Isabel ^a   Yeomans, Larisa ^a   Keyari, Charles M ^a   Davis, Peg ^a   Bilsky, Edward J ^a   Egleton, Richard D ^a   Yamamura, Henry I ^a   Jacobsen, Neil E ^a   Tollin, Gordon ^a   Hruby, Victor J ^a   Porreca, Frank ^a   Polt, Robin ^a  

^a University of Arizona   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD; CONFORMATIONS; DISSOCIATION; MICELLES; NUCLEAR MAGNETIC RESONANCE;

BLOOD-BRAIN BARRIER (BBB); GLYCOPEPTIDES; NUCLEAR OVERHAUSER EFFECTS (NOE); PHOSPHATIDYL CHOLINE (PC); PLASMON WAVEGUIDE RESONANCE (PWR);

PROTEINS;

BETA ENDORPHIN; GLYCOPEPTIDE; NANOPARTICLE; PHOSPHATIDYLCHOLINE; WATER;

ARTICLE; BLOOD BRAIN BARRIER; CIRCULAR DICHROISM; DISSOCIATION CONSTANT; ENDOCYTOSIS; LIPID BILAYER; MICELLE; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; MOLECULAR MIMICRY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; NUCLEAR OVERHAUSER EFFECT; PROTEIN CONFORMATION; PROTEIN GLYCOSYLATION; PROTEIN STRUCTURE; PROTON NUCLEAR MAGNETIC RESONANCE; STRUCTURE ANALYSIS; SURFACE PLASMON RESONANCE; TRANSCYTOSIS;

AMINO ACID SEQUENCE; BETA-ENDORPHIN; BLOOD-BRAIN BARRIER; CIRCULAR DICHROISM; GLYCOPEPTIDES; LIPID BILAYERS; MICELLES; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; POLYTETRAFLUOROETHYLENE; PROTEIN STRUCTURE, SECONDARY; SODIUM DODECYL SULFATE; SURFACE PLASMON RESONANCE; WATER;

EID: 20244377223     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja0432158     Document Type: Article

References (116)

1. McNally, G. P.; Akil, H. Opioid peptides and their receptors: overview and function in pain modulation. In Neuropsychopharmacology: the Fifth Generation of Progress; Davis, K. L., Charney, D., Coyle, J. T., Nemeroff, C., Eds.; Lippincott Williams & Wilkins: Philadelphia, 2002, Chapter 3, pp 35-46.
2. Adessi, C.; Soto, C. Cur. Med. Chem. 2002, 9, 963-978.
3. Reese, T. S.; Karaovsky, M. J. J. Cell. Biol. 1967, 34, 207-217.
4. Pardridge, W. M. Introduction to the Blood-Brain Barrier, Cambridge University Press: New York, 1993.
5. Breig, N. H.; Fredericks, W. R.; Holoway, H. W.; Soncrant, T. T.; Rapoport, S. I. J. Pharmacol. Exp. Ther. 1988, 245, 581-586.
6. Hruby, V. J.; Mosberg, H. I. Peptides 1982, 3, 329-336.
7. (b) Mosberg, H. I., Hurst, R., Hruby, V. J.; Galligan, J. J.; Burks, T. F.; Gee, K.; Yamamura, H. I. Biochem. Biophys. Res. Commun. 1982, 106, 506-512.
8. Hruby, V. J. Biopolymers 1993, 33, 1073-1082.
9. Bodor, N.; Prokai, L.; Wu, W. M.; Farag, H.; Jonalagadda, S.; Kawamura, M.; Simpkins, J. Science 1992, 257, 1698-1700.
10. (b) Rousselle, C.; Clair, P.; Lefauconnier, J. M.; Kaczorek, M.; Scherrmann, J. M.; Temsamani, J. Mol. Pharmacol. 2000, 57, 679-686.
11. Albert, R.; Marbach, P.; Bauer, W.; Briner, U.; Flicker, G.; Bruns, C.; Pless, J. Life Sci. 1993, 53, 517-525.
12. (b) Polt, R.; Porreca, F.; Szabo, L. Z.; Bilsky, E. J.; Davis, P.; Abbruscato, T. J.; Davis, T. P.; Harvath, R.; Yamamura, H. I.; Hruby, V. J. Proc. Natl. Acad. Sci., U.S.A. 1994, 91, 7114-7118.
13. (c) Negri, L.; Lattanzi, R.; Tabacco, F.; Orru, L.; Severini, C.; Scolaro, B.; Rocchi, R. J. Med. Chem. 1999, 42, 400-404.
14. (d) Tomatis, R.; Marastoni, M.; Balboni, G.; Guerrini, R.; Capasso, A.; Sorrentino, L.; Santagada, V.; Caliendo, G.; Lazarus, L. H.; Salvadori S. J. Med. Chem. 1997, 40, 2948-2952.
15. Egleton, R. D.; Mitchell, S. A.; Huber, J. D.; Palian, M. M.; Polt, R.; Davis, T. P. J. Pharmacol. Exp. Ther. 2001, 299, 967-972.
16. (b) Bilsky, E. J.; Egleton, R. D.; Mitchell, S. A.; Palian, M. M.; Davis, P. Huber, J. D.; Jones, H.; Yamamura, H. I.; Janders, J.; Davis, T. P.; Porreca, F.; Hruby, V. J.; Polt, R. J. Med. Chem. 2000, 43, 2586-2590.
17. (c) Elmagbari, N. O.; Egleton, R. D.; Palian, M. M.; Lowery, J. J.; Schmid, W. R.; Davis, P.; Navratilova, E.; Dhanasekaran, M.; Keyari, C. M.; Yamamura, H. I.; Porreca, F.; Hruby, V. J.; Polt, R.; Bilsky, E. J. J. Pharmacol. Exp. Ther. 2004, 311, 290-297.
18. Palian, M. M.; Boguslavsky, V. I.; O'Brien, D. F.; Polt, R. J. Am. Chem. Soc. 2003, 125, 5823-5831.
19. Susaki, H.; Suzuki, K.; Yamada, H.; Okuno, S.; Watanabe, H. K. Biol. Pharm. Bull. 1999, 22, 1094-1098.
20. (b) Suzuki, K.; Susaki, H.; Okuno, S.; Sugiyama, Y. J. Pharmacol. Exp. Ther. 1999, 288, 57-64.
21. (c) Suzuki, K., Susaki, H.; Okuno, S.; Yamada, H.; Watanabe, H. K.; Sugiyama, Y. J. Pharmacol. Exp. Ther. 1999, 288, 888-897.
22. Egleton, R. D.; Mitchell, S. A.; Huber, J. D.; Janders, J.; Stropova, D.; Polt, R.; Yamamura, H. I.; Hruby, V. J.; Davis, T. P. Brain Res. 2000, 881, 37-46.
23. Gysin, B.; Schwyzer, R. Arch. Biochem. Biophys. 1983, 225, 467-474.
24. Lee, N. M.; Smith, A. P. Life Sci. 1980, 26, 1459.
25. Graf, L.; Cseh, G.; Barat, E.; Ronai, A. Z.; Szekely, J.; Kennesey, A.; Bajusz, S. Ann. N. Y. Acad. Sci. 1977, 297, 63.
26. Schwyzer, R. Biochemistry 1986, 25, 6336-6342.
27. Taylor, J. W.; Osterman, D. G.; Miller, R. J.; Kaiser, E. T. J. Am. Chem. Soc. 1981, 103, 6965-6966.
28. Taylor, J. W.; Kaiser, E. T.; Int. J. Pept. Protein Res. 1989, 34, 75-80.
29. (b) Blanc, J. P.; Taylor, J. W.; Miller, R. J.; Kaiser, E. T. J. Biol. Chem. 1983, 258, 8277-8284.
30. (c) Taylor, J. W.; Miller, R. J.; Kaiser, E. T. J. Biol. Chem. 1983, 258, 4464-4471.
31. Taylor, J. W.; Miller, R. J.; Kaiser, E. T. Mol. Pharmacol. 1982, 22, 657-666.
32. (b) Taylor, J. W.; Kaiser, E. T. Methods Enzymol. 1987, 154, 473-499.
33. Goldstein, A.; Fischli, W.; Lowney, L. I.; Hunkapiller, M.; Hood, L. Proc. Natl. Acad. Sci. USA. 1981, 78, 7219-7223.
34. Chavkin, C.; Goldstein, A. Proc. Natl. Acad. Sci., U.S.A. 1981, 78, 6543-6547.
35. Renugopalakrishnan, V.; Rapaka, R. S.; Huang, S.-G.; Moore, S.; Houston, T. B. Biochem. Biophys. Res. Commun. 1988, 151, 1220-1225.
36. (b) Zhou, N.; Gibbons, W. A. J. Chem. Soc., Perkin Trans. 1986, 2, 637-644.
37. (c) Maroun, R.; Mattice, W. L. Biochem. Biophys. Res. Commun. 1981, 103, 442-446.
38. (d) Spadaccini, R.; Crescenzi, O.; Picone, D.; Tancredi, T.; Temussi, A. J. Peptide Sci. 1999, 5, 306-312.
39. Tessmer, M.; Kallick, D. A. Biochemistry 1997, 36, 1971-1981.
40. Luna, F.-D. T.; Collins, N.; Stropova, D.; Davis, P.; Yamamura, H. I.; Porreca, F.; Hruby, V. J. J. Med. Chem. 1996, 39, 1136-1141.
41. Zhang, C.; Miller, W.; Valenzano, K. J.; Kyle, D. J. J. Med. Chem. 2002, 45, 5280-5286.
42. Egleton, R. D.; Bilsky, E. J.; Tollin, G.; Dhanasekaran, M.; Lowery, J.; Alves, I.; Davis, P.; Porreca, F.; Yamamura, H. I.; Yeomans, L.; Keyari, C. M.; Polt, R. Tetrahedron Asym. 2005, 16, 65-75.
43. Buck, M. Quart. Rev. Biophys. 1998, 31, 297-355.
44. Henry, G. D.; Sykes, B. D. Methods Enzymol. 1994, 239, 515-535.
45. (b) Damberg, P.; Jarvet, J.; Gräslund, A. Methods Enzymol. 2001, 339, 271-285.
46. Vold, R.; Prosser, R. S. J. Magn. Reson. 1996, 113, 267-271.
47. (b) Struppe, J.; Whiles, J. A.; Vold, R. R. Biophys. J. 2000, 78, 281-289.
48. (c) Struppe, J.; Komives, E. A.; Taylor, S. S.; Vold, R. R. Biochemistry 1998, 37, 15523-15527.
49. Luchette, P. A.; Vetman, T. N.; Prosser, R. S.; Hancock, R. E. W.; Nieh, M. P.; Glinka, C. J.; Krueger, S.; Katsaras, J. Biochim. Biophys. Acta 2001, 1513, 83-94.
50. (b) Glover, K. J.; Whiles, J. A.; Wu, G.; Yu, J.; Deems, R.; Struppe, J. O.; Strark, R. E., Komives, E. A.; Vold, R. R. Biophys. J. 2001, 81, 2163-2171.
51. Sanders, C. R.; Landis, G. C. Biochemistry 1995, 34, 4030-4040.
52. Marcotte, I.; Separovic, F.; Auger, M.; Gagné, S. M. Biophys. J. 2004, 86, 1587-1600.
53. (b) Chatterjee, C.; Mukhopadhyay, C. Biopolymers 2003, 70, 512-521.
54. Bárány-Wallje, E.; Andersson, A.; Gräslund, A.; Mäler, L. FEBS Lett. 2004, 567, 265-269.
55. (b) Lindberg, M.; Biverståhl, H.; Gräslund, A.; Mäler, L. Eur. J. Biochem. 2003, 270, 3055-3063.
56. Adam, G.; Delbruck, M. In Structural chemistry and molecular biology, pp 198-ff, Rich, R., Davidson, N., Eds.; Freeman & Co.: San Francisco, 1968.
57. Pauling, L.; Corey, R. B.; Branson, H. R. Proc. Natl. Acad. Sci. U.S.A. 1951, 37, 205-211.
58. (b) Perutz, M. F. New X-ray Evidence on the Configuration of Polypeptide Chains. Nature 1951, 167, 1053.
59. (c) Chothia, C.; Annu. Rev. Biochem. 1984, 53, 537-572.
60. Segrest, J. P.; Jackson, R. L.; Morrisett, J. D.; Gotto, A. M., Jr. FEBS Lett. 1974, 38, 247-253.
61. Cornette, J. L.; Cease, K. B.; Margalit, H.; Spouge, J. L.; Berzofsky, J. A.; DeLisi, C. J. Mol. Biol. 1987, 195, 659-685.
62. (b) Epand, R. M.; Shai, Y.; Segrest, J. P.; Anantharamaiah, G. M. Biopolymers 1995, 37, 319-338.
63. Segrest, J. P.; Loof, H. D.; Dohlman, J. G.; Brouillette, C. G.; Anantharamaiah, G. M. Proteins: Struct., Funct., Genet. 1990, 8, 103-117.
64. Fernandez-Carneado, J., Kogan, M. J., Pujals, S., Giralt, E. Amphipathic peptides and drug delivery. Biopolymers (Peptide Science) 2004, 76, 196-203.
65. Lin, J. C.; Barua, B.; Andersen, N. H. J. Am. Chem. Soc. 2004, 126, 13679-13684.
66. (b) Lifson, S.; Roig, A. J. Chem. Phys. 1961, 34, 1963-1974.
67. (b) Doig, A. J.; Chakrabartty, A.; Klingler, T. M.; Baldwin, R. L. Biochemistry 1994, 33, 3396-3403.
68. Zajac, J.-M.; Gacel, G.; Petit, F.; Dodey, P.; Rosignol, P.; Roques, B. P. Biochem. Biophys. Res. Commun. 1983, 111, 390-397.
69. Chakrabarthy, A.; Baldwin, R. L. Adv. Protein Chem. 1995, 46, 141-176.
70. Marqusee, S.; Robbins, R. L.; Baldwin, R. L. Proc. Natl. Acad. Sci., U.S.A. 1989, 86, 5286-5290.
71. Karle, I. L.; Balaram, P. Biochemistry 1990, 29, 6747-6756.
72. Marqusee, S.; Baldwin, R. L. Proc. Natl. Acad. Sci., U.S.A. 1987, 84, 8898-8902.
73. Bracken, C.; Gulyas, J.; Taylor, J. W.; Baum, J. J. Am. Chem. Soc. 1994, 116, 6431.
74. Schneider, J. P.; Kelly, J. W. Chem. Rev. 1995, 95, 2169-2187.
75. Lyu, P. C.; Liff, M. I.; Marky, L. A.; Kallenbach, N. R. Science 1990, 250, 669-673.
76. (b) O'Neil, K. T.; DeGrado, W. F. Science 1990, 250, 646-651.
77. (c) Padmanabhan, S.; Marqusee, S.; Ridgeway, T.; Laue, T. M.; Baldwin, R. L. Nature 1990, 344, 268-270.
78. Presta, L. G.; Rose, G. D. Science 1988, 240, 1632-1641.
79. (b) Richardson, J. S.; Richardson, D. C., Amino acid preferences for specific locations at the ends of α-helices. Science 1988, 240, 1648-1652.
80. (c) Aurora, R.; Rose, G. D. Protein Sci. 1995, 4, 1325-1336.
81. Abbbadi, A.; Mcharfi, M.; Aubry, A.; Premilat, S.; Boussard, G.; Marraud, M. J. Am. Chem. Soc. 1991, 113, 2729-2735.
82. Mitchell, S. A.; Pratt, M. R.; Hruby, V. J.; Polt, R. J. Org. Chem. 2001, 66, 2327-2342.
83. Chan, W. C.; White, P. D. In Fmoc Solid phase peptide synthesis: A practical approach; Chan, W. C.; White, P. D., Eds.; Oxford, 2000; pp 41-76.
84. Scholtz, J. M.; Marqusee, S.; Baldwin, R. L.; York, E. J.; Stewart, J. M.; Santoro, M.; Bolen, D. W. Proc. Natl. Acad. Sci., U.S.A. 1991, 88, 2854-2858.
85. Rance, M. J. Magn. Reson. 1987, 74, 557-564.
86. Kumar, A.; Ernst, R. R.; Wuthrich, K., Biochem. Biophys. Res. Commun. 1985, 63, 207-213.
87. Davis, D. G.; Bax, A., J. Am. Chem. Soc. 1985, 107, 2821-2823.
88. Piotto, M.; Daudek, V.; Sklenar, V., J. Biomol. NMR. 1992, 2, 661-665.
89. Hagler, A. T.; Lifson, S.; Dauber, P. J. Am. Chem. Soc. 1979, 101, 5122-5130.
90. (b) Dauber-Osguthorpe, P.; Roberts, V. A.; Osguthorpe, D. J.; Wolff, J.; Genest, M.; Hagler, A. T. Proteins: Structure, Function and Genetics 1988, 4, 31-47.
91. Wuthrich, K.; Billeter, M.; Braun, W. J. Mol. Biol. 1983, 169, 949-961.
92. Mueller, P.; Rudin, D. O.; Tien, H. T.; Wescott, W. C. Nature 1962, 194, 979-980.
93. Aravinda, S.; Shamala, N.; Roy, R. S.; Balaram, P. Proc. Indian Acad. Sci. (Chem. Sci.) 2003, 115, 373-400.
94. (b) Dhanasekaran, M.; Fabiola, F.; Pattabhi, V.; Durani, S. J. Am. Chem. Soc. 1999, 121, 5575-5576.
95. Woody, R. W. Methods Enzymol. 1995, 246, 34-71.
96. Dyson, H. J.; Rance, M.; Houghten, R. A.; Wright, P. E.; Lerner, R. A. J. Mol. Biol. 1988, 201, 201-217.
97. (b) Werner, J. H.; Dyer, R. B.; Fesinmeyer, R. M.; Andersen, N. H. J. Phys. Chem. B 2002, 106, 487-494.
98. Millhauser, G. L. Biochemistry 1995, 34, 3873-3877.
99. (b) Andersen, N. H.; Liu, Z. H.; Prickett, K. S. FEBS Lett, 1996, 399, 47-52.
100. Applequist, J. J. Chem. Phys. 1979, 71, 4332-4338.
101. (b) Manning, M. C.; Woody, R. W. Biopolymers 1991, 31, 569-586.
102. Toniolo, C.; Polese, A.; Formaggio, F.; Crisma, M.; Kamphuis, J. J. Am. Chem. Soc. 1996, 118, 2744-2745.
103. (b) Toniolo, C.; Formaggio, F.; Tognon, S.; Broxterman, Q. B.; Huang, R.; Setnicka, V.; Keiderling, T. A.; McColl, I. H.; Hecht, L.; Barron, L. D. Biopolymers 2004, 75, 32-45
104. Wuthrich, K. NMR of Proteins and Nucleic Acids; Wiley: New York, 1986.
105. Wishart, D. S.; Sykes, B. D. Methods Enzymol. 1994, 239, 363-393.
106. Rizo, J.; Blanco, F. J.; Kobe, B.; Bruch, M. D.; Gierasch, L. M. Biochemistry 1993, 32, 4881-4894.
107. (b) Merutka, G.; Morikis, D.; Brüschweiler, R.; Wright, P. E. Biochemistry 1993, 32, 13089-13097.
108. Merutka, G.; Dyson, H. J.; Wright, P. E. J. Biomol. NMR. 1995, 5, 14-24.
109. Helenius, A.; McCaslin, D. R.; Fries, E.; Tanford, C. Methods Enzymol. 1979, 56, 734-749.
110. Gunasekaran, K.; Nagarajaram, H. A.; Ramakrishnan, C.; Balaram, P. J. Mol. Biol. 1998, 275, 917-932.
111. Plasmon waveguide resonance (PWR) is slightly different from surface plasmon resonance (SPR) in that one can obtain information both in the s-mode (parallel to the membrane surface) and the p-mode (perpendicular to the membrane surface). Schuck, P. Annu. Rev. Biophys. Biomol. Struct. 1997, 26, 541-566.
112. Salamon, Z.; Macleod, H. A.; Tollin, G. Biophys. J. 1997, 73, 2791-2797.
113. Salamon, Z.; Macleod, H. A.; Tollin, G. Biochim. Biophys. Acta 1997, 1331, 117-129.
114. (b) Salamon, Z.; Macleod, H. A.; Tollin, G. Biochim. Biophys. Acta 1997, 1331, 131-152.
115. Salamon, Z.; Brown, M. F.; Tollin, G. Trends Biochem. Sci. 1999, 24, 213-219.
116. This notion of two states has been referred to as biousian. See ref 27 for more details.